RISPERDAL CONSTA vs RITLECITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RISPERDAL CONSTA vs RITLECITINIB: Safety Overview
| Metric | RISPERDAL CONSTA | RITLECITINIB |
|---|---|---|
| Total FAERS Reports | 140 | 1,441 |
| Deaths Reported | 29 | 1 |
| Death Rate | 20.7% | 0.1% |
| Hospitalizations | 56 | 47 |
| Average Patient Age | 45.0 yrs | 34.7 yrs |
| % Female Patients | N/A | 65.0% |
| FDA Approval Date | N/A | Jun 23, 2023 |
| Manufacturer | N/A | U.S. Pharmaceuticals |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |